Intech Investment Management LLC reduced its holdings in shares of The Clorox Company (NYSE:CLX – Free Report) by 26.5% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 37,626 shares of the company’s stock after selling 13,545 shares during the quarter. Intech Investment Management LLC’s holdings in Clorox were worth $5,761,000 as of its most recent SEC filing.
Other hedge funds have also bought and sold shares of the company. Fortitude Family Office LLC bought a new stake in Clorox during the fourth quarter worth $29,000. Venturi Wealth Management LLC boosted its holdings in shares of Clorox by 308.5% in the 1st quarter. Venturi Wealth Management LLC now owns 192 shares of the company’s stock worth $29,000 after purchasing an additional 145 shares in the last quarter. Northwest Financial Advisors bought a new stake in shares of Clorox in the 4th quarter valued at about $29,000. Core Wealth Advisors Inc. bought a new stake in shares of Clorox in the 4th quarter valued at about $29,000. Finally, First United Bank & Trust bought a new stake in shares of Clorox in the 4th quarter valued at about $31,000. 78.53% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of research firms have weighed in on CLX. DA Davidson reiterated a “neutral” rating and set a $162.00 target price on shares of Clorox in a report on Wednesday, April 17th. Wells Fargo & Company cut their target price on Clorox from $135.00 to $130.00 and set an “underweight” rating on the stock in a research note on Wednesday, July 10th. UBS Group lowered their price target on Clorox from $164.00 to $159.00 and set a “neutral” rating on the stock in a report on Wednesday, May 1st. Barclays lowered their price target on Clorox from $132.00 to $122.00 and set an “underweight” rating on the stock in a report on Friday. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on Clorox from $155.00 to $151.00 and set a “hold” rating on the stock in a report on Wednesday, April 17th. Five investment analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and an average target price of $144.00.
Clorox Trading Down 0.9 %
CLX traded down $1.17 on Friday, hitting $135.14. The company had a trading volume of 827,185 shares, compared to its average volume of 1,166,653. The company has a market cap of $16.78 billion, a PE ratio of 70.02, a PEG ratio of 2.01 and a beta of 0.39. The Clorox Company has a 12-month low of $114.68 and a 12-month high of $169.14. The company has a quick ratio of 0.53, a current ratio of 0.90 and a debt-to-equity ratio of 9.73. The business’s fifty day simple moving average is $134.20 and its 200 day simple moving average is $142.95.
Clorox (NYSE:CLX – Get Free Report) last posted its quarterly earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.38. The firm had revenue of $1.81 billion during the quarter, compared to the consensus estimate of $1.87 billion. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The company’s revenue was down 5.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.51 earnings per share. Equities research analysts expect that The Clorox Company will post 5.92 EPS for the current year.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Further Reading
- Five stocks we like better than Clorox
- What is Forex and How Does it Work?
- Why This AI Stock is Rising Despite Tech Sell-Off
- 10 Best Airline Stocks to Buy
- MarketBeat Week in Review – 7/15 – 7/19
- What is MarketRank™? How to Use it
- Investors Are Moving into Bonds and Small Cap Stocks: Here’s Why
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.